INFLUVAC TETRA susp inj 2024/25 10 ser pré 0.5 ml
7680680870105
CH-68087
J07BB02
08.08.
1 / 3
google
Details
- Product number
- 6808704
- CPT
- -
- Packaging group
- 10
- Unit
- Fertigspritze(n)
- Composition
- haemagglutininum influenzae A (H1N1) (Virus-Stamm A/Victoria/4897/2022 (H1N1)-pdm09: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Thailand/8/2022 (H3N2)-like: reassortant virus derived from A/California/122/2022, SAN-022) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Austria/1359417/2021 -like: reassortant virus BVR-26 derived from B/Austria/1359417/2021 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Phuket/3073/2013 (Yamagata lineage)) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 2.01 mg, kalium 0.08 mg, residui: cetrimidum, formaldehydum, gentamicini sulfas, polysorbatum 80, ovalbuminum.
Articles (1)
Influvac Tetra 0.5 ml, Injektionssuspension
Injektionssuspension
10
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
haemagglutininum influenzae A (H1N1)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae A (H3N2)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae B
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum influenzae B
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
kalii chloridum
|
- | Substance | HNIDK |
|
kalii dihydrogenophosphas
|
- | Substance | HNIDK |
|
dinatrii phosphas dihydricus
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
calcii chloridum dihydricum
|
- | Substance | HNIDK |
|
magnesii chloridum hexahydricum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
2.01 MG | Substance | HBESI |
|
kalium
|
0.08 MG | Substance | HBESI |
|
cetrimidum
|
- | Substance | RESI |
|
formaldehydum
|
- | Substance | RESI |
|
gentamicini sulfas
|
- | Substance | RESI |
|
polysorbatum 80
|
- | Substance | RESI |
|
ovalbuminum
|
- | Substance | HNIDK |
Authorization holder
Viatris Pharma GmbH
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 68087
- Drug name
- Influvac Tetra, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- J07BB02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/10/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INFLUVAC TETRA susp inj 2024/25 10 ser pré 0.5 ml
- Description (DE)
- INFLUVAC TETRA Inj Susp 2024/25 10 Fertspr 0.5 ml
- Market launch
- 07/08/2024
- Market withdrawal
- 31/12/2025
- Narcotic (BTM)
- No